Back to top
more

CONMED Corporation (CNMD)

(Delayed Data from NYSE)

$137.94 USD

137.94
163,445

-0.11 (-0.08%)

Updated Jul 30, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.57%
2Buy19.14%
3Hold10.74%
4Sell6.46%
5Strong Sell3.16%
S&P50011.27%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for CNMD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for CONMED Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 27 26 18 33 27
Receivables 177 189 182 167 148
Notes Receivable 0 0 0 0 0
Inventories 195 165 155 141 136
Other Current Assets 17 18 21 16 19
Total Current Assets 417 397 374 357 331
Net Property & Equipment 111 119 113 116 122
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 7 6 5 5 4
Intangibles 1,120 1,151 814 817 817
Deposits & Other Assets 97 102 63 63 56
Total Assets 1,752 1,775 1,369 1,358 1,329
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 53 56 54 42 42
Current Portion Long-Term Debt 18 14 18 15 10
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 50 54 43 34 32
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 68 65 46 59 30
Total Current Liabilities 190 188 161 150 114
Mortgages 0 0 0 0 0
Deferred Taxes/Income 58 74 81 78 119
Convertible Debt 0 0 0 0 0
Long-Term Debt 735 755 439 472 488
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 59 47 26 27 27
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,043 1,065 707 727 748
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 383 379 342 334 329
Retained Earnings 457 471 465 440 407
Other Equity -64 -59 -56 -49 -59
Treasury Stock 68 81 89 94 97
Total Shareholder's Equity 709 710 662 631 581
Total Liabilities & Shareholder's Equity 1,752 1,775 1,369 1,358 1,329
Total Common Equity 709 710 662 631 581
Shares Outstanding 28.60 28.30 28.10 27.90 27.80
Book Value Per Share 24.79 25.10 23.57 22.63 20.88

Fiscal Year End for CONMED Corporation falls in the month of December.

All items in Millions except Per Share data.

6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Assets          
Cash & Equivalents NA 37 27 36 35
Receivables NA 164 177 167 143
Notes Receivable NA 0 0 0 0
Inventories NA 206 195 183 176
Other Current Assets NA 18 17 19 25
Total Current Assets NA 424 417 404 379
Net Property & Equipment NA 109 111 112 113
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 7 0 0
Intangibles NA 1,112 1,120 1,127 1,134
Deposits & Other Assets NA 101 97 100 98
Total Assets NA 1,747 1,752 1,743 1,724
Liabilities & Shareholders Equity 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Notes Payable NA 0 0 0 0
Accounts Payable NA 56 53 57 40
Current Portion Long-Term Debt NA 20 18 17 15
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 41 50 45 37
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 65 68 60 59
Total Current Liabilities NA 182 190 179 151
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 57 58 73 65
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 725 735 760 790
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 59 48 43
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,021 1,043 1,060 1,049
Shareholders Equity 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 389 383 381 377
Retained Earnings NA 461 457 439 438
Other Equity NA -63 -64 -62 -64
Treasury Stock NA 62 68 76 77
Total Shareholder's Equity NA 726 709 683 675
Total Liabilities & Shareholder's Equity NA 1,747 1,752 1,743 1,724
Total Common Equity 0 726 709 683 675
Shares Outstanding 29.00 29.00 28.60 28.60 28.50
Book Value Per Share 0.00 25.02 24.79 23.89 23.68